Overtime to ensure production Guiyang pharmaceutical companies continue to ensure the supply of key prevention and treatment drugs

Read Time:4 Minute, 35 Second

Currently, with the optimal adjustment of the epidemic prevention and control policy, the whole country has entered a new stage of epidemic prevention and control. In the face of this change, the majority of pharmaceutical enterprises also combined with their own reality, through overtime to ensure production, do a good job of epidemic prevention and drug reserves and other active measures to continue to ensure the supply of market demand for key control drugs. So, what is the current production situation of local pharmaceutical enterprises? Can they meet the people’s demand for drugs? Ltd. and Guizhou Taibang Biological Products Co., Ltd. and how they continue to do a good job in the production of related drugs!

Pantech Pharmaceutical: daily production capacity of 20,000 bottles of oral medicine for colds and flu

Ltd. was established in 1993, the company is located in Baiyun District, Guiyang City, Jinghong Industrial Park. With the strong support of Baiyun District Committee and District Government, the company now has three modern production lines of capsules, oral solutions and creams, mainly producing anti-allergy, tonic, cold and flu, digestive tract and other oral compound preparations; at the same time, the company’s procurement of raw materials, workshop production management to intermediate product testing, as well as business sales services and other processes are strictly enforced in accordance with national standards.

Into the company’s production workshop, a modern oral solution production line is running in an orderly manner, the continuous production of the current urgent need for oral chemical preparations for colds and flu – aminogalactam solution (cold solution). Two staff members were carefully checking the labeling and sealing of the products one by one.

“Aminogalactam solution (cold liquid) is mainly used to reduce fever, headache, sore throat, nasal congestion, runny nose, sneezing, coughing, coughing and other related symptoms caused by cold or flu.”

Ltd. told reporters, combined with market demand and the requirements of the higher authorities, the company’s production line, production cycle has been adjusted in a timely manner, for the time being, all 60 staff members work overtime every day, continue to do a good job in the production of aminoglycoside solution (cold solution). In the next step, it will also adjust the production of drug types in a timely manner according to the market demand and the arrangement from above.

“In terms of production, Aminoguai Min solution (cold solution) can produce about 20,000 bottles per day, a production cycle (7 days) down, can produce about 140,000 bottles. Next, our company will also fully cooperate with the current epidemic prevention and control policy, obliged to shoulder the responsibility and responsibility of pharmaceutical enterprises, go all out to do a good job in the production of basic anti-epidemic drugs, as far as possible to meet the needs of the public with drugs, but also to contribute to the prevention and control of the epidemic in Guizhou Province.” The person in charge added.

Taibang Guizhou: fully guarantee the local epidemic prevention drug reserve

Ltd. was established in 1996, which is a wholly-owned subsidiary of Taibang Biological Group Company, located in Zhulin Village, Huaxi District, Guiyang City. It is the first GMP certified blood products enterprise, the leading biopharmaceutical enterprise in Guizhou Province, the national designated blood products manufacturer, and the national high-tech enterprise.

Through the real-time monitoring system of information technology, the reporter observed that the production line was continuously producing sedative human immunoglobulin for the treatment of severe neocrown pneumonia. As one of the main representative products of the company, the static injection human immunoglobulin is mainly used for the treatment of autoimmune diseases such as severe infection, neonatal sepsis and primary thrombocytopenic purpura, and also for the clinical treatment of patients with severe neoconiosis.

The reporter learned that the company is a high-tech enterprise integrating R&D, production and sales. The raw plasma is collected through the company’s five monopoly plasma stations. The company also implements high standards in plasma packaging, storage and transportation, i.e. plasma is quick-frozen after collection and transported in the cold chain throughout the whole process, so as to maintain the biological activity of the protein in plasma to the maximum; the R&D process relies on the group’s R&D team, and provides technical support and scientific research guarantee for the company’s R&D through academic exchanges and joint training of talents with the same industry at home and abroad, and employs domestic and foreign experts as technical leaders; the production process, through protein In the production stage, through advanced equipment and facilities such as protein separation system and refining and liquid preparation room, we have created a blood product production line with automation, informationization and intelligence.

“Combined with the current market demand and the requirements of the higher authorities, our company continues to reserve the production of static injection human immunoglobulin to ensure the production.” The person in charge of Guizhou Taibang Biological Products Co., Ltd. told the reporter that in the next step, it will also combine with the actual situation of the enterprise, obliged to shoulder the responsibility and responsibility of the pharmaceutical enterprises, continue to fully cooperate with the current epidemic prevention and control policy, in accordance with the relevant requirements of the higher level for the epidemic prevention and control of Guizhou region to do a good job of guaranteeing the supply of drug reserves, so as to contribute to the health and safety of the general public.